NCT04357925|Active Not Recruiting
Quality of Life in Prostate Cancer Patients
QoLProstateMQ
Loading search results
QoLProstateMQ
Sponsor study identifier
Secondary identifiers
OTHER · ANSM
observational
304
1 country
1
Study Start
May 6, 2020
Actual (reported)Primary Completion
December 31, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 31, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Recording cancer data in cancer registries is essential for producing reliable population-based data for service planning, monitoring and evaluation. Prostate cancer (PCa) remains the most frequent type of cancer in terms of incidence and mortality in men in the Caribbean. The quality of life PCa cohort will assess quality of life and patient outcomes in Martinique using a digital platform for patient-reported outcome measures.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 17, 2020
Actual (reported)April 22, 2020
Actual (reported)May 6, 2020
Actual (reported)December 31, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
December 31, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Evaluation of overall Quality of Life: Questionnaire
Change of quality of life questionnaire related to sexual dysfunction
At the date of diagnosis of the disease, at 1 year, 3 years and 5 years
Evaluation of overall Quality of Life: Questionnaire
Change of quality of life questionnaire related to urinary troubles
At the date of diagnosis of the disease, at 1 year, 3 years and 5 years
Patients with prostate cancer diagnosed in Martinique in differents units care.
CHU de Martinique
Fort-de-France, Martinique
Clarisse CONTARET-JOACHIM
CHU Martinique
First Submitted
April 17, 2020
First Posted
April 22, 2020
Study Start
May 6, 2020
Actual (reported)Primary Completion
December 31, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer
Contact the study team to confirm eligibility.
Study Completion
December 31, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
March 31, 2026
Record last verified: 2026-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: